|
|
||||||||
Journal of the American College of Nutrition, Vol 15, Issue 4 325-339, Copyright © 1996 by American College of Nutrition
JOURNAL ARTICLE |
P. Khosla and K. C. Hayes
Foster Biomedical Research Laboratory, Brandeis University, Waltham, Massachusetts 02254, USA.
Trans fatty acids (t-FA) are geometrical isomers of unsaturated fatty acids that assume a saturated fatty acid-like configuration. Human diets contain t-FA derived from animal sources (e.g., dairy products and ruminant meats), but most are supplied by products containing industrially hydrogenated vegetable oils (e.g., margarines, shortenings and baked goods). Typical intake of t-FA in American diets has been estimated to be between 8-15 g/day, although wide variation exists between individuals. Human clinical studies since 1990 have revealed that relative to cis-monounsaturated fatty acids (i.e., oleic acid), t-FA increase total cholesterol (TC) and low density lipoprotein cholesterol (LDL-C), and tend to decrease high density lipoprotein cholesterol (HDL-C) concentrations. Additionally, t-FA tend to increase the atherogenic lipoprotein (a). Thus, t-FA induce an adverse plasma lipid profile (increased ratios of TC/LDL-C and LDL-C/HDL-C), which represents increased risk for coronary heart disease. The effects of t-FA on LDL-C and HDL-C appear to be directly related to intake and clinically measurable above 3%en as t-FA. The cholesterol-raising ability of t-FA is analogous to that of the 12-16 carbon saturated fatty acids, possibly reflecting increased LDL production or delayed LDL clearance. By contrast, t-FA are unlike the saturated fatty acids in their depression of HDL-C. Preliminary evidence suggests that at least part of their impact on lipoproteins reflects increased serum cholesteryl ester transfer protein activity, i.e., increased transfer of cholesteryl esters from HDL to LDL. Since the adverse effects of t-FA on human plasma lipids may be confined to specific isomers, future studies delineating their effects are warranted.
This article has been cited by other articles:
![]() |
R. Friesen and S. M. Innis Trans Fatty Acids in Human Milk in Canada Declined with the Introduction of Trans Fat Food Labeling J. Nutr., October 1, 2006; 136(10): 2558 - 2561. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. R. Matthan, F. K. Welty, P. H. R. Barrett, C. Harausz, G. G. Dolnikowski, J. S. Parks, R. H. Eckel, E. J. Schaefer, and A. H. Lichtenstein Dietary Hydrogenated Fat Increases High-Density Lipoprotein apoA-I Catabolism and Decreases Low-Density Lipoprotein apoB-100 Catabolism in Hypercholesterolemic Women Arterioscler Thromb Vasc Biol, June 1, 2004; 24(6): 1092 - 1097. [Abstract] [Full Text] |
||||
![]() |
A. Baylin, E. K. Kabagambe, A. Ascherio, D. Spiegelman, and H. Campos High 18:2 Trans-Fatty Acids in Adipose Tissue Are Associated with Increased Risk of Nonfatal Acute Myocardial Infarction in Costa Rican Adults J. Nutr., April 1, 2003; 133(4): 1186 - 1191. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. R. Matthan, K. Cianflone, A. H. Lichtenstein, L. M. Ausman, M. Jauhiainen, and P. J. H. Jones Hydrogenated fat consumption affects acylation- stimulating protein levels and cholesterol esterification rates in moderately hypercholesterolemic women J. Lipid Res., November 1, 2001; 42(11): 1841 - 1848. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. A Kummerow, Q. Zhou, and M. M Mahfouz Effect of trans fatty acids on calcium influx into human arterial endothelial cells Am. J. Clinical Nutrition, November 1, 1999; 70(5): 832 - 838. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M Innis and D J. King trans Fatty acids in human milk are inversely associated with concentrations of essential all-cis n-6 and n-3 fatty acids and determine trans, but not n-6 and n-3, fatty acids in plasma lipids of breast-fed infants Am. J. Clinical Nutrition, September 1, 1999; 70(3): 383 - 390. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. V. Subbaiah, V. S. Subramanian, and M. Liu Trans unsaturated fatty acids inhibit lecithin: cholesterol acyltransferase and alter its positional specificity J. Lipid Res., July 1, 1998; 39(7): 1438 - 1447. [Abstract] [Full Text] |
||||
![]() |
P. Khosla, T. Hajri, A. Pronczuk, and K. C. Hayes Replacing Dietary Palmitic Acid with Elaidic Acid (t-C18:1Delta 9) Depresses HDL and Increases CETP Activity in Cebus Monkeys J. Nutr., March 1, 1997; 127(3): 531 - 531. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |